---
schema_version: "secwatch.filing_event.v1"
accession: "0001842952-21-000005"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2021-11-01T23:59:59+00:00"
generated_at: "2026-06-28T15:52:54.225926+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics appoints Jennifer Minai-Azary as CFO with $365K base salary

## Summary
- Jennifer Minai-Azary appointed CFO; previously CFO at Millendo Therapeutics, led merger with Tempest.
- Employment agreement: $365,000 annual base salary; target annual bonus of 40% of base salary.
- Granted non-qualified stock options for 52,753 shares, vesting monthly over 3 years.
- Severance: 9 months base salary if terminated without cause; change-in-control triggers 12 months salary plus full equity vesting.
- Press release also notes Alex Levit was appointed Chief Legal Officer in April 2021.

## SEC filing metadata
- accession: 0001842952-21-000005
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2021-11-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000184295221000005/0001842952-21-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000184295221000005/cntx-20211101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001842952-21-000005
- JSON: https://secwatch.observer/filing/0001842952-21-000005.json
- Plain text: https://secwatch.observer/filing/0001842952-21-000005.txt

## Key facts
- Executive change
  Jennifer Minai-Azary was appointed as Chief Financial Officer at Context Therapeutics Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On November 1, 2021, Context Therapeutics Inc. (the “Company”) appointed Jennifer Minai-Azary as the Company’s Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842952/000184295221000005/0001842952-21-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.